Innlanz Limited

INL

AU0000199002

Other Specialty Retailers

Delayed Australian S.E. Other stock markets 05:40:56 24/05/2024 am IST			5-day change	1st Jan Change
0.01 ^AUD	-.--%		-.--%	-16.67%

15/05	Innlanz to Delist from ASX, Roll Out Share Buyback Scheme	MT
15/05	Innlanz Limited announces an Equity Buyback for 63,263,608 shares, representing 20.2% for AUD 0.82 million.	CI

Mediland Pharm Limited Appoints Peter French as Director

February 01, 2019 at 02:53 am IST

Mediland Pharm Limited appointed Peter French as Director of the company, effective from November 1, 2018.

Latest news about Innlanz Limited

Innlanz to Delist from ASX, Roll Out Share Buyback Scheme	15/05	MT
Innlanz Limited announces an Equity Buyback for 63,263,608 shares, representing 20.2% for AUD 0.82 million.	15/05	CI
Innlanz Limited authorizes a Buyback Plan.	15/05	CI
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2023	07/03	CI
Innlanz Limited Announces Resignation of Jhon Shen as Executive Director	27/02	CI
Innlanz Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/23/28	CI
Innlanz Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/22/31	CI
Innlanz Limited Announces the Resignation of Tracey Cray as Director, Effective 31 July 2022	29/22/29	CI
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2021	01/22/01	CI
Mediland Pharm Limited Announces Change of Principal Place of Business and Registered Office Address	20/21/20	CI
Mediland Pharm Limited Reports Earnings Results for the Full Year Ended June 30, 2021	31/21/31	CI
Mediland Pharm Limited completed the acquisition of Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd.	29/21/29	CI
Mediland Pharm Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2020	26/21/26	CI
Mediland Pharm : Board Proposes New Zealand Hotel Buy; Shares Fall 10%	04/20/04	MT
Mediland Pharm Limited agreed to acquire Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. for AUD 2.5 million.	04/20/04	CI
Mediland Pharm Limited Declares No Dividend for the Year of 2020	23/20/23	CI
Mediland Pharm Limited Announces Audited Consolidated Earnings Results for the Full Year Ended June 30, 2020	23/20/23	CI
Mediland Pharm Limited Reports Earnings Results for the Full Year Ended June 30, 2020	31/20/31	CI
Mediland Pharm Limited Enters into Contract with Intercontinental Hotels Group as Supplier of Mediland-Branded Hand Sanitiser	03/20/03	CI
Mediland Pharm Limited Reports Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2019	21/20/21	CI
250,000,000 Ordinary Shares of Mediland Pharm Limited are subject to a Lock-Up Agreement Ending on 20-FEB-2020.	20/20/20	CI
Mediland Pharm Limited acquired Enti Financial Pty Ltd for AUD 1 million.	30/20/30	CI
Mediland Pharm Limited Approves the Election of Leo Cui as Director	28/19/28	CI
Mediland Pharm Limited completed the acquisition of Ian’s Health Lounge business.	01/19/01	CI

Innlanz Limited is an Australia-based retailer of cosmetics, jewelry, health, well-being, and wool products, serving the inbound Chinese tourism market in Australia and New Zealand. The Company, through its subsidiary, Ixora Investment Pty Ltd, owns the Heartland Ambassador Hamilton Hotel in New Zealand. Its other subsidiaries include Mediland Pharm NZ Ltd and The Collection Hotels and Resorts Pty Ltd.

Sector

Other Specialty Retailers

Calendar

14/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Health Food Stores

	1st Jan change	Capi.
INNLANZ LIMITED	-16.67%	2.08M
THE BETTER BEING CO.	-.--%	843M
DXN HOLDINGS BHD.	-.--%	671M
NATURAL GROCERS BY VITAMIN COTTAGE, INC.	+34.88%	492M
ZINZINO AB	+19.13%	231M
MARX BIOTECH CO., LTD.	-.--%	151M
NANJING SINOLIFE UNITED COMPANY LIMITED	+113.04%	59.29M